UHN
Radiotheranostics
Core
The UHN Radiotheranostics Core (UHNRC) is a research core within the University Health Network (UHN) in Toronto, Canada.
About
The UHNRC provides radiopharmaceuticals for the investigational and commercial use from a facility operating in accordance with GMP regulations.
Radiopharmaceuticals are part of an advanced imaging technology that uses medical isotopes to assess and treat patients at a cellular level. Using imaging radiopharmaceuticals, physicians can detect diseases earlier and more accurately monitor the effectiveness of treatments. Targeted therapeutic radiopharmaceuticals can be used to provide personalized treatment of cancers.
Team

Luke Brzozowski
Executive Director, Translational Research and Core Facilities, UHN

Julia Publicover
Director, Translational Research and Innovation, Techna, UHN

Ur
Metser
Division Head of Molecular Imaging, UHN

David Green
Staff Scientist, Techna, UHN

Carlos Varón
Clinical Engineer, UHN

Carlos
Ruiz
Engineering Technologist at Techna, UHN

Arthur
Wong
Financial Business Manager, UHN

Dragan Gligorov
Business Development Specialist, UHN

Shima Marand
Administrative Assistant II, UHN